Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    9673301 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 Diabetes
Conditions: Diabetes Mellitus Type 2;   Hypercholesterolemia
Interventions: Drug: ezetimibe;   Drug: simvastatin;   Drug: Ezetimibe 10/Simvastatin 20
To Top

† Indicates status has not been verified in more than two years